SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Aug-22 4:25 PM View: | Inhibikase Therapeutics, Inc. (IKT) | 16-Aug-22 | Private Purchase | 5,000 | $0.80 | $4,000.00 | < 1% 5.33M to 5.34M | |
31-May-22 10:16 AM View: | Inhibikase Therapeutics, Inc. (IKT) | 27-May-22 | Private Purchase | 5,000 | $0.98 | $4,880.00 | < 1% 5.33M to 5.33M | |
23-May-22 4:57 PM View: | Inhibikase Therapeutics, Inc. (IKT) | 20-May-22 | Private Purchase | 10,000 | $0.60 | $6,000.00 | < 1% 5.32M to 5.33M | |
04-Jan-22 9:25 PM View: | Inhibikase Therapeutics, Inc. (IKT) | 03-Jan-22 | Option Exercise | 21,853 | $2.02 | $44,143.10 | < 1% 5.29M to 5.32M | |
19-Nov-21 8:13 AM View: | Inhibikase Therapeutics, Inc. (IKT) | 17-Nov-21 | Market Purchase | 23,589 | $1.97 | $46,558.10 | < 1% 5.29M to 5.32M | (4%) |
19-Aug-21 7:46 AM View: | Inhibikase Therapeutics, Inc. (IKT) | 17-Aug-21 | Option Exercise | 21,853 | $2.02 | $44,143.10 | < 1% 5.27M to 5.29M | (3%) |
18-May-21 5:46 PM View: | Inhibikase Therapeutics, Inc. (IKT) | 14-May-21 | Payment of Exercise | 16,918 | $4.59 | $77,653.60 | (< 1%) 5.29M to 5.27M | |
18-May-21 5:46 PM View: | Inhibikase Therapeutics, Inc. (IKT) | 14-May-21 | Option Exercise | 43,707 | $0.38 | $16,608.70 | < 1% 5.24M to 5.29M |